A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus - DES-DIABETES


Patients with diabetes mellitus and coronary artery disease (CAD) have been shown to have better outcomes with drug-eluting stents (DES) compared with bare-metal stents (BMS). This trial was aimed at performing a head-to-head comparison between sirolimus-eluting stents (SES) with paclitaxel-eluting stents (PES) in diabetic patients with CAD.